Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $47.1 Million - $57.5 Million
395,500 Added 541.04%
468,600 $55.8 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $4.2 Million - $5.02 Million
34,200 Added 87.92%
73,100 $10.4 Million
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $3.97 Million - $5.29 Million
38,900 New
38,900 $4.99 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $46.5 Million - $56.2 Million
499,600 Added 164.18%
803,900 $89.3 Million
Q4 2021

Feb 10, 2022

BUY
$95.88 - $117.08 $27 Million - $32.9 Million
281,400 Added 1228.82%
304,300 $34.1 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $1.29 Million - $1.61 Million
19,000 Added 487.18%
22,900 $1.92 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $1.46 Million - $1.65 Million
-21,800 Reduced 84.82%
3,900 $263,000
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $217,226 - $250,920
3,400 Added 15.25%
25,700 $1.8 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $2.44 Million - $3.2 Million
-49,400 Reduced 68.9%
22,300 $1.34 Million
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $6.53 Million - $7.42 Million
-140,900 Reduced 66.27%
71,700 $3.75 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $7.71 Million - $8.77 Million
185,700 Added 690.33%
212,600 $9.79 Million
Q3 2018

Nov 09, 2018

SELL
$46.76 - $51.24 $6.26 Million - $6.86 Million
-133,900 Reduced 83.27%
26,900 $1.27 Million
Q4 2017

Feb 09, 2018

BUY
$47.53 - $53.73 $2.83 Million - $3.2 Million
59,600 Added 58.89%
160,800 $8.63 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $4.16 Million - $4.98 Million
101,200
101,200 $4.87 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.